Ufovax and The Scripps Research Institute (TSRI) signed a SFP (Sponsor Funded Project) Agreement for Ufovax to sponsor a five-year research program in Prof. Jiang Zhu’s lab to develop nanoparticle vaccines targeting viruses utilizing class-I and class-II fusion mechanisms. These viruses include HIV, HCV, Ebola,… [Read more]
